Probiotic in Patients With Bile Acid Malabsorption/Diarrhea

Recruiting N/A Interventional Study
Bile Acid Malabsorption Bile Acid Diarrhea
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
24 (estimated)
Sponsor
Mayo Clinic · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to assess effect of the DSF probiotic on fecal bile acid levels in patients with BAM.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: * Prior diagnosis of bile acid malabsorption documented in the medical history based on * either serum C4 \>52.5ng/mL, or * fecal 48h total BA excretion \>2337 μmol/48h, or * primary BA \>5% 48h stool collection or \>10% in single stool sample. * 7-day stool dairy with an…
Contacts

John Damianos, MD

5072842511

damianos.john@mayo.edu

CONTACT